Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Different rhBNP Treatment Courses in Acute Decompensated Heart Failure
ChiCTR2500109663Phase 4Not yet recruiting
- Sponsor
- The Second Affiliated Hospital of Fujian Medical University
- Start
- Sep 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of nesiritide in heart failure (HF) and Acute Heart Failure (AHF) (2 arms), sponsored by The Second Affiliated Hospital of Fujian Medical University. Primary endpoint: Clinical remission rate at Day 5. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
nesiritide
03
Conditions
heart failure (HF)Acute Heart Failure (AHF)
Beyond the preview
Go deeper on ChiCTR2500109663.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500109663.